Author Archives: Warren Woessner

ALCHEMISTS’ LINK TO CHEM/PHARMA GOLD

Posted on January 15, 2010 by Warren Woessner

This link below will lead you to a wealth of recent chem/pharma caselaw and policy materials organized by Kevin Buckley for his lectures on Biotechnology Law at Washington University in St. Louis School of Law. Like the fabled Alchemists’ Stone, … Continue reading →

Posted in 2010 Patent News | Tagged , , | Leave a comment

BACK TO THE O.K. CORRAL – SHOULD PROFESSORS MANAGE IP LICENSING?

Posted on January 13, 2010 by Warren Woessner

Last summer, Bob Litan and Lesa Mitchell of the Kauffman Foundation sent a short memo to Esther Lee at the Dept. of Commerce entitled “Accelerating the Commercialization of Government-Funded University-Based Research.” Although the Foundation, based in Kansas City MO, has … Continue reading →

Posted in Tech Transfer | Tagged , , , , , , , , | 1 Comment

Privilege Primer

Posted on January 8, 2010 by Warren Woessner

Guest Posting from Ron Shutz Case: Keefe v. Bernard, 2009 W.L. 346738 (Oct. 30, 2009). Topic: Corporate Attorney/Client & Work Product Privilege Facts The attorney representing both the doctor and his corporate employer in a medical malpractice action interviewed an … Continue reading →

Posted in Post-Grant Issues | Tagged , , , | Leave a comment

You Say Tomato . . . I Say Tah-mah-to . . . Hewlett-Packard Company v. Acceleron LLC

Posted on December 28, 2009 by Warren Woessner

Authored by Ronald J Schutz of Robins Kaplan Miller & Ciresi LLP The Federal Circuit says: “declaratory judgment jurisdiction,” even if the patent holder’s notice letter waltzes around buy cialis online uk phrases like “infringement” or “assertion.” In Hewlett-Packard Company … Continue reading →

Posted in Litigation Issues | Tagged , , , , | Leave a comment